CWA Asset Management Group LLC Sells 462 Shares of Danaher Co. (NYSE:DHR)

CWA Asset Management Group LLC lowered its holdings in shares of Danaher Co. (NYSE:DHR) by 13.1% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 3,054 shares of the conglomerate’s stock after selling 462 shares during the period. CWA Asset Management Group LLC’s holdings in Danaher were worth $701,000 as of its most recent filing with the SEC.

Several other large investors have also bought and sold shares of DHR. Fort Pitt Capital Group LLC increased its position in Danaher by 3.2% during the 3rd quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate’s stock worth $66,194,000 after purchasing an additional 7,421 shares in the last quarter. Good Life Advisors LLC bought a new position in shares of Danaher in the 3rd quarter valued at $217,000. Oak Thistle LLC bought a new stake in Danaher during the 2nd quarter worth $363,000. Harvest Portfolios Group Inc. increased its holdings in Danaher by 1.2% in the 3rd quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate’s stock worth $56,233,000 after purchasing an additional 2,465 shares in the last quarter. Finally, Stifel Financial Corp raised its position in Danaher by 1.3% in the third quarter. Stifel Financial Corp now owns 847,348 shares of the conglomerate’s stock valued at $235,583,000 after purchasing an additional 11,216 shares during the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Stock Up 0.3 %

Danaher stock opened at $239.00 on Wednesday. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The firm’s fifty day moving average price is $236.17 and its two-hundred day moving average price is $254.11. The firm has a market capitalization of $172.62 billion, a price-to-earnings ratio of 45.61, a price-to-earnings-growth ratio of 4.33 and a beta of 0.83. Danaher Co. has a 1-year low of $222.53 and a 1-year high of $281.70.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. The business had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The company’s quarterly revenue was up 3.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.02 EPS. On average, equities research analysts predict that Danaher Co. will post 7.5 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be issued a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a yield of 0.45%. The ex-dividend date is Friday, December 27th. Danaher’s dividend payout ratio (DPR) is presently 20.61%.

Analyst Ratings Changes

Several research firms have recently issued reports on DHR. KeyCorp upped their price objective on Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a research note on Wednesday, October 23rd. Stephens reaffirmed an “overweight” rating and set a $315.00 price target on shares of Danaher in a research note on Wednesday, October 23rd. Robert W. Baird reduced their price objective on shares of Danaher from $278.00 to $277.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 23rd. StockNews.com lowered Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, December 14th. Finally, Evercore ISI upped their price target on Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a research report on Tuesday, October 1st. Six analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $286.80.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.